InvestorsHub Logo
Followers 3170
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: None

Monday, 04/17/2017 8:16:18 AM

Monday, April 17, 2017 8:16:18 AM

Post# of 30393

On April 17, 2017 , Apricus Biosciences, Inc. (the “ Company ”), reported that, as of March 31, 2017, the Company had approximately $3.8 million in cash and cash equivalents. This amount is preliminary, has not been audited and is subject to change upon completion of the Company’s review of its unaudited consolidated financial statements as of and for the three months ended March 31, 2017.



Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News